AnalystsEliana Merle
Eliana Merle's Stock Forecasts

Analyst Ranking
Top 13%
#672 out of 5200 analysts
Average Return
+12.82%
Win Rate
52%48 out of 93
Risk vs Reward
Poor
Good

Eliana Merle's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
Iveric Bio IncISEE
+237.97%$11.01$37.21
2022-08-02 -
2023-05-03
Strong Buy
Cymabay Therapeutics IncCBAY
+213.84%$1.59$4.99
2020-03-13 -
2021-03-12
Strong Buy
Kymera Therapeutics IncKYMR
+180.67%$31.14$87.40
2025-05-13 -
2026-02-20
Strong Buy
Cymabay Therapeutics IncCBAY
+166.61%$12.07$32.18
2023-08-14 -
2024-02-14
Strong Buy
Kadmon Holdings IncKDMN
+148.04%$3.83$9.50
2021-05-21 -
2021-11-09
Strong Buy

Eliana Merle Analyst Color

Get additional color on Eliana Merle's coverage of popular stocks

Eliana Merle's Stock Coverage

Name / TickerNo. RatingsRatingPrice TargetUpside/DownsideActionDate
Vertex Pharmaceuticals IncVRTX
2Strong Buy$607.00+27.28%Maintains
4 days ago
Kymera Therapeutics IncKYMR
4Strong Buy$133.00+52.17%Maintains
24 days ago
Uniqure NvQURE
5Hold$31.00+32.31%Initiates Coverage On
24 days ago
Tyra Biosciences IncTYRA
2Strong Buy$59.00+86.83%Initiates Coverage On
24 days ago
Tpg IncTPG
1Strong Buy$78.00+75.24%Initiates Coverage On
24 days ago
Sagimet Biosciences IncSGMT
2Hold$8.00+50.38%Initiates Coverage On
24 days ago
Ptc Therapeutics IncPTCT
1Strong Buy$119.00+68.41%Upgrades
24 days ago
Mbx Biosciences IncMBX
1Strong Buy$66.00+89.71%Initiates Coverage On
24 days ago
Madrigal Pharmaceuticals IncMDGL
6Strong Buy$964.00+121.60%Initiates Coverage On
24 days ago
Inventiva SaIVA
2Strong Buy$18.00+166.67%Initiates Coverage On
24 days ago
Insmed IncINSM
1Strong Buy$231.00+40.08%Initiates Coverage On
24 days ago
Gossamer Bio IncGOSS
4Strong Buy$9.00+322.54%Initiates Coverage On
24 days ago
Ascendis Pharma AASND
3Strong Buy$342.00+52.00%Initiates Coverage On
24 days ago
4d Molecular Therapeutics IncFDMT
1Strong Buy$33.00+265.85%Initiates Coverage On
24 days ago
Bridgebio Pharma IncBBIO
5Strong Buy$80.00+17.41%Initiates Coverage On
24 days ago
Apellis Pharmaceuticals IncAPLS
8Hold$24.00+7.72%Initiates Coverage On
24 days ago
Alnylam Pharmaceuticals IncALNY
4Strong Buy$527.00+56.76%Initiates Coverage On
24 days ago
Moderna IncMRNA
9Hold$34.00-31.82%Assumes
a month ago
Altimmune IncALT
2Strong Buy$24.00+447.95%Maintains
6 months ago
Rapt Therapeutics IncRAPT
4Hold$9.00-84.46%Maintains
6 months ago
Anaptysbio IncANAB
5Hold$20.00-63.09%Maintains
6 months ago
Biomarin Pharmaceutical IncBMRN
3Strong Buy$114.00+77.90%Maintains
7 months ago
Sarepta Therapeutics IncSRPT
1Hold$12.00-36.44%Downgrades
7 months ago
Prokidney CorpPROK
1Strong Buy$8.00+282.78%Maintains
7 months ago
Curevac NvCVAC
3Hold$5.50+18.03%Downgrades
8 months ago
Arvinas IncARVN
5Strong Buy$21.00+75.15%Maintains
9 months ago
89bio IncETNB
3Strong Buy$38.00N/AMaintains
a year ago
Akero Therapeutics IncAKRO
4Strong Buy$109.00N/AMaintains
a year ago
Zentalis Pharmaceuticals IncZNTL
4Hold$2.20N/AMaintains
a year ago
Revolution Medicines IncRVMD
2Strong Buy$71.00N/AMaintains
a year ago
Biontech SeBNTX
4Hold$131.00N/AMaintains
a year ago
Kodiak Sciences IncKOD
3Hold$5.00N/AMaintains
2 years ago
Terns Pharmaceuticals IncTERN
2Strong Buy$18.00N/AMaintains
2 years ago
Cymabay Therapeutics IncCBAY
5Hold$32.50N/ADowngrades
2 years ago
Iveric Bio IncISEE
2Hold$40.00N/ADowngrades
3 years ago
Monte Rosa Therapeutics IncGLUE
1Strong Buy$22.00N/AInitiates Coverage On
3 years ago
Regenxbio IncRGNX
1Strong Buy$47.00N/AMaintains
4 years ago
Kadmon Holdings IncKDMN
1Strong Buy$9.00N/AInitiates Coverage On
5 years ago
Amicus Therapeutics IncFOLD
2Strong Buy$16.00N/AInitiates Coverage On
5 years ago
Galapagos NvGLPG
2Hold$134.00N/AMaintains
6 years ago
Alexion Pharmaceuticals IncALXN
1Hold$121.00N/AInitiates Coverage On
6 years ago
Cartesian Therapeutics IncRNAC
1Strong Buy$10.00N/AInitiates Coverage On
6 years ago
Tesaro IncTSRO
1Strong Buy$68.00N/AMaintains
7 years ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.